drugset / Trial / NCT04271839
Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients
Phase 4
Withdrawn
Mundipharma Pharmaceuticals S.L.
Alpha Bioresearch S.L. · collabDynamic Solutions · collab
RandomizedParallel-groupOpen-labelOther
Summary
Clinical trial to demonstrate whether, in patients with moderate asthma, to treat with IC / LABA a medium dose, but not controlled, to achieve a similar degree of control by making a progressive increase of that treatment (CI / LABA a high dose) versus switching to fluticasone / Formoterol K-Haler at medium dose, under conditions of usual clinical practice.
Timeline
- Start
- 2020-06-11
- Primary completion
- 2021-05
- Completion
- 2021-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | — | Inhaled |
| Subject | Formoterol | Other / unclassified | — | Inhaled |